Glassman Wealth Services Vanda Pharmaceuticals Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$3.38 - $4.58 $730 - $989	216 Added 174.19%	340 $1,000
Q3 2023 Nov 13, 2023	SELL	$4.28 - $6.57 $226 - $348	-53 Reduced 29.94%	124 $0
Q2 2023 Aug 08, 2023	BUY	$5.9 - $6.95 $17 - $20	3 Added 1.72%	177 $1,000
Q1 2023 May 04, 2023	BUY	$6.18 - $7.99 $772 - $998	125 Added 255.1%	174 $1,000
Q4 2022 Feb 06, 2023	BUY	$6.87 - $10.96 $336 - $537	49 New	49 $0

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $271M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.